ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
NuChem Sciences has acquired OmegaChem, creating what it says is Canada’s largest contract research organization (CRO) providing drug discovery chemistry. Three Canadian investment companies are putting up a combined $30 million to support the deal. NuChem says it will have 200 scientists and support staffers. Formed in 2011, NuChem employs many chemists who worked at drug firms such as AstraZeneca that closed labs in Quebec.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter